Form 4 for NVCT Nuvectis Pharma, Inc.
Accepted 2023-07-24 00:00:00 ET · period of report 2023-07-20 · accession 0001104659-23-083470 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| M | 2023-07-24 | 2023-07-20+ | NVCT | Mosseri Marlio Charles | 10% | P - Purchase | $14.47 | +8,238 | 2.58M | +0.3% | +$119.2K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2023-07-20 | P | A | 5,394 | $14.40 | 2,577,156 | D | — | — | (F1) Reflects the weighted average purchase price. The range of prices for the shares purchased was $14.10 to $14.42. The reporting person effected multiple same-way open market purchase transactions on the same day at different prices through a trade order executed by a broker-dealer. The reporting person reported on a single line all such transactions that occurred within a one-dollar price range. The reporting person hereby undertakes to provide upon request by the Securities and Exchange Commission staff, the issuer, or a shareholder of the issuer, full information regarding the number of shares purchased at each separate price. |
| 2 | Common | Common Stock | 2023-07-21 | P | A | 2,844 | $14.61 | 2,580,000 | D | — | — |